The judgment was to permit Par to market its generic formulation of Ultram ER in the US, on condition that it receive final regulatory approval from the ...
... attempt to manufacture and market the generic version of the analgesic tramadol ER (brandname-Ultram ER) infringes patent coverage of the innovator. ...
